Comparative efficacy of indacaterol in chronic obstructive pulmonary disease Full Text
International Journal of COPD,  Clinical Article

Ribeiro M et al. – Data from trials with the novel once–daily β2–agonist, indacaterol, indicate superior bronchodilation and clinical efficacy over twice–daily long–acting β2–agonists and at least equipotent bronchodilation as once–daily tiotropium. Bronchodilators are central in the symptomatic management of chronic obstructive pulmonary disease (COPD). It is likely that once–daily dosing of a bronchodilator would be a significant convenience and probably a compliance–enhancing advantage, leading to improved overall clinical outcomes in patients with COPD.

  • Long–acting bronchodilators have been shown to improve multiple clinical outcomes in chronic obstructive pulmonary disease (COPD) including lung function, symptoms, dyspnea, quality of life, and exacerbations.
  • Indacaterol is a novel, inhaled, long–acting β2–agonist providing 24–hour bronchodilation with once–daily dosing.
  • It is currently approved for the maintenance treatment of COPD to be administered as 150 or 300 µg once–daily doses as licensed in many countries and 75 µg as licensed in the US by means of a single–dose dry powder inhaler.
  • The data from clinical development support a favorable safety and tolerability profile within the β2–agonist drug class, with no relevant issues identified.
  • Current evidence indicates that indacaterol is suitable for use as first–line monotherapy in COPD patients with moderate disease (Global Initiative for Chronic Obstructive Lung Disease [GOLD] stage II) and beyond that do not require an inhaled corticosteroid (ICS) as per GOLD guidelines, or in combination with an ICS in severe or very severe patients with repeated exacerbations.

Please login or register to follow this author.
Are you sure you want to Unfollow this Author?
► Click here to access Full Text, PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

Your Unread Messages in Pulmonology

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Pulmonology Articles

1 Cytotoxic agents in sarcoidosis: Which one should we choose? Current Opinion in Pulmonary Medicine, August 15, 2014    Review Article

2 Endobronchial ultrasound-guided transbronchial needle aspiration vs conventional transbronchial needle aspiration in the diagnosis of sarcoidosis Chest, September 9, 2014    Clinical Article

3 Withdrawal of inhaled glucocorticoids and exacerbations of COPD New England Journal of Medicine, September 12, 2014    Evidence Based Medicine    Clinical Article

4 Efficacy and safety of a fixed-dose combination of indacaterol and glycopyrronium for the treatment of COPD: A systematic review Chest, August 21, 2014    Evidence Based Medicine

5 Cardiac glycosides use and the risk of lung cancer: A nested case–control study Full Text BMC Cancer, August 22, 2014    Free full text    Clinical Article

6 Risk of dementia among patients with asthma: a nationwide longitudinal study Journal of the American Medical Directors Association, August 28, 2014    Clinical Article

7 Azithromycin maintenance treatment in patients with frequent exacerbations of chronic obstructive pulmonary disease (COLUMBUS): A randomised, double-blind, placebo-controlled trial The Lancet Respiratory Medicine, May 15, 2014    Clinical Article

8 Benralizumab for chronic obstructive pulmonary disease and sputum eosinophilia: A randomised, double-blind, placebo-controlled, phase 2a study The Lancet Respiratory Medicine, September 16, 2014    Clinical Article

9 The use of N-acetylcysteine in respiratory diseases Current Respiratory Medicine Reviews, July 17, 2014    Review Article

10 Cost-effectiveness of salmeterol/fluticasone propionate combination (Advair) in uncontrolled asthma in Canada Respiratory Medicine, September 22, 2014    Clinical Article

11 Volume assured versus pressure preset non-invasive ventilation for compensated ventilatory failure in COPD Respiratory Medicine, September 23, 2014    Clinical Article

12 Efficacy of azithromycin in the treatment of bronchiectasis Respirology, September 9, 2014    Clinical Article

13 Value of different bronchoscopic sampling techniques in diagnosis of sarcoidosis: A prospective study of 151 patients Journal of Bronchology & Interventional Pulmonology, July 21, 2014    Clinical Article

14 Once-daily indacaterol 75 µg in moderate- to-severe COPD: Results of a Phase IV study assessing time until patients’ perceived onset of effect Full Text International Journal of COPD, September 10, 2014    Free full text    Clinical Article

15 SQ HDM SLIT-tablet (ALK) in treatment of asthma – Post hoc results from a randomised trial Respiratory Medicine, September 24, 2014    Clinical Article

16 Combination long-acting {beta}-agonists and inhaled corticosteroids compared with long-acting {beta}-agonists alone in older adults with chronic obstructive pulmonary disease JAMA, September 18, 2014    Evidence Based Medicine    Clinical Article

17 Association between serum angiotensin-converting enzyme 2 level with postoperative morbidity and mortality after major pulmonary resection in non-small cell lung cancer patients Heart, Lung, and Circulation, September 12, 2014    Clinical Article

18 Interactive videogame as rehabilitation tool of patients with chronic respiratory diseases: Preliminary results of a feasibility study Respiratory Medicine, September 17, 2014    Clinical Article

19 A randomized study of formoterol fumarate in a porous particle metered-dose inhaler in patients with moderate-to-severe COPD Respiratory Medicine, September 25, 2014    Clinical Article

20 Microfibrillar-associated protein 4: A potential biomarker of chronic obstructive pulmonary disease Respiratory Medicine, September 19, 2014    Clinical Article

Indexed Journals in Pulmonology: Chest, Thorax, American Journal of Respiratory and Critical Care Medicinemore

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Connect with us, stay current.

Receive the latest mecial news
updates for free via email

Sign up!

Subscribe to our free RSS feeds:

Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Close